The Association of Women with Breast Cancer (DACMA) has donated a check for 8,000 euros to IDIBELl and ICO dedicated to breast cancer research. This donation counted on the participation of Belén García, the mayor of Sant Joan Despí, where DACMA has its headquarters, who wanted to accompany the entity members in this event.
The DACMA Association donates 8,000 euros for breast cancer research Read More »
The most innovative projects in the healthcare and biomedical sector were presented on December the 16th at the fourth edition of the Accelerator Meeting Point (AMP), organized by the Business Development and Innovation Area of the Biomedical Research Institute of Bellvitge (IDIBELL). The fourth edition of the AMP has counted on the participation of AIISEM,
The new trial allows human papilloma virus (HPV) detection and genotyping with the same sensitivity as other commonly used PCRs but following a much simpler procedure.
New diagnostic technique for HPV detection in oropharyngeal cancers Read More »
Un estudio del IDIBELL y el Hospital Universitario de Bellvitge ha descrito como las vacunas han cambiado la distribución de los distintos serotipos de neumococo.
Scientists describe how vaccination has affected bacterial variants that cause pneumonia Read More »
A research group of IDIBELL and UB has revealed the importance of the function of NRF2, a protein that regulates the expression of some genes in response to oxidative radicals, in the maintenance of bone tissue.
Scientists discover an essential mechanism for maintaining bone density Read More »
The new program, following IDIBELL’s strategic plan, aims to promote interaction between both institutions and reinforce scientific collaboration.
The IDIBELL Neurometabolic Diseases team, which is also part of CIBERER, plans to start the study in early 2022 with the anti-inflammatory dimethyl fumarate in patients with this condition.
New clinical trial for adrenoleukodystrophy, a rare disease of brain metabolism Read More »
Under the title, “Re-definition of lung adenocarcinoma transcriptional subtypes using integrative bioinformatic approaches”, David Cordero, Ania Alay, Raúl Marín, Xavier Solé, and Ernest Nadal have collaborated in the work.
According to a study by IDIBELL and the University of Barcelona, when the levels of nutrients and energy decrease, tumor cells are able to detect it and enter a low-energy mode, during which they store all the necessary material to later reactivate their growth.
In adverse conditions, tumor cells create ribosome reservoirs that allow them to survive Read More »
Aptadel comprise the first generation of companies accelerated at the BCN Health Booster, an initiative promoted by the University of Barcelona (UB), Barcelona Science Park (PCB) and the Barcelona City Council, with support from Barcelona Activa and collaboration from Biocat. The project was created under the Barcelona Science Plan and is an example of collaboration
The spin-off Aptadel selected to be part of BCN Health Booster Read More »
